Nanjing, China

Dan Xu

This inventor holds 3 USPTO granted patents and 9 published patent applications and 2 EPO patents. Top assignees: Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Flag Chemical Industry Co., Ltd.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dan Xu. Retrieved from https://idiyas.com/inventor/dan-xu-sru41euj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 33.3

 

Average Co-Inventor Count = 7.9

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Dan Xu

Introduction

Dan Xu is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of AKT inhibitors. With a total of 3 patents to his name, Xu's work is recognized for its potential impact on medical treatments.

Latest Patents

Among his latest patents is a unit dosage composition of an AKT inhibitor. This pharmaceutical composition is designed in unit dosage form and includes a compound of formula I-0 or a pharmaceutically acceptable salt thereof. The mass of the compound I-0 or its salt ranges from 5 mg to 400 mg calculated as free base. Additionally, Xu has developed an AKT inhibitor that specifically relates to a compound represented by formula I or a pharmaceutically acceptable salt thereof. This invention also provides a preparation method and its use in the prevention and/or treatment of diseases mediated by AKT protein kinase.

Career Highlights

Dan Xu has worked with prominent companies in the pharmaceutical industry, including Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. and Jiangsu Flag Chemical Industry Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Xu has collaborated with various professionals, including Changyou Ma and Jian Wu. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Dan Xu's contributions to the field of pharmaceuticals, particularly through his patents on AKT inhibitors, highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…